表紙
市場調查報告書

全球囊狀纖維化症市場

Cystic Fibrosis

出版商 Global Industry Analysts, Inc. 商品編碼 478081
出版日期 內容資訊 英文 161 Pages
商品交期: 最快1-2個工作天內
價格
全球囊狀纖維化症市場 Cystic Fibrosis
出版日期: 2020年02月01日內容資訊: 英文 161 Pages
簡介

本報告提供全球囊狀纖維化症市場相關調查,提供疾病概要與市場的今後預測,各地區趨勢,及加入此市場的主要企業簡介。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 市場概要
    • 囊狀纖維化症:概要
    • 罹患率
    • 治療方法
    • 競爭模式
  • 囊狀纖維化症領域的研究
    • 研究開發領域
    • 基因治療
    • 研究結果與創新
    • 診斷和個體化治療的診斷指南
    • 開發平台藥物
    • 各開發階段平台藥物
  • 疾病概要
    • 囊狀纖維化症
    • 遺傳基因變異
    • 遺傳的風險
    • 病理學
    • 症狀
    • 併發症
    • 診斷方法
  • 囊狀纖維化症治療:概要
    • 現有的治療方法
    • 一般的藥物
    • 囊狀纖維化症管理的藥物分析
    • 肺部感染的抗生素治療
    • 粘液溶解藥
    • 胰酵素補充療法
    • 調整劑
    • 支氣管擴張劑
    • 追加的治療
    • 外科及其他技術
  • 臨床試驗
  • 產品上市/核准
  • 近幾年的產業活動
  • 各臨床階段參與企業
  • 全球主要加入企業
    • AbbVie Inc.
    • Galapagos NV
    • Genentech, Inc.
    • Gilead Sciences, Inc.
    • Novartis AG
    • Vertex Pharmaceuticals
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 歐洲
  • 其他各國

第4章 競爭環境

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6233

Cystic Fibrosis market worldwide is projected to grow by US$7.3 Billion, driven by a compounded growth of 13.3%. Medication, one of the segments analyzed and sized in this study, displays the potential to grow at over 14.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$9 Billion by the year 2025, Medication will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$286.4 Million to the region's size and clout in the next 5 to 6 years. Over US$234.3 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Medication will reach a market size of US$457.1 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 17.3% over the next couple of years and add approximately US$1.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • AbbVie Inc.
  • Galapagos NV
  • Genentech
  • Gilead Sciences Inc.
  • Novartis AG
  • Vertex Pharmaceuticals Incorporated

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Cystic Fibrosis - A Prelude
  • Recent Market Activity
  • CF Disease Prevalence: A Brief Note
  • Treatment Modalities for Cystic Fibrosis
  • CFTR Modulators: Key Drug Category
  • Competitive Scenario
  • Vertex: At the Forefront of Cystic Fibrosis Therapeutics
  • Global Competitor Market Shares
  • Cystic Fibrosis Competitor Market Share Scenario Worldwide (in %): 2020 & 2029

2. FOCUS ON SELECT PLAYERS

  • AbbVie Inc. (USA)
  • Galapagos NV (Belgium)
  • Genentech, Inc. (USA)
  • Gilead Sciences, Inc. (USA)
  • Novartis AG (Switzerland)
  • Vertex Pharmaceuticals (USA)

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Cystic Fibrosis Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Cystic Fibrosis Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Cystic Fibrosis Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Medication (Treatment Method) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Medication (Treatment Method) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Medication (Treatment Method) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Devices (Treatment Method) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Devices (Treatment Method) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Devices (Treatment Method) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Other Treatment Methods (Treatment Method) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Other Treatment Methods (Treatment Method) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Other Treatment Methods (Treatment Method) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Cystic Fibrosis Market Share (in %) by Company: 2020 & 2025
    • Market Analytics
    • TABLE 13: United States Cystic Fibrosis Market Estimates and Projections in US$ Million by Treatment Method: 2018 to 2025
    • TABLE 14: Cystic Fibrosis Market in the United States by Treatment Method: A Historic Review in US$ Million for 2009-2017
    • TABLE 15: United States Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 16: Canadian Cystic Fibrosis Market Estimates and Forecasts in US$ Million by Treatment Method: 2018 to 2025
    • TABLE 17: Canadian Cystic Fibrosis Historic Market Review by Treatment Method in US$ Million: 2009-2017
    • TABLE 18: Cystic Fibrosis Market in Canada: Percentage Share Breakdown of Sales by Treatment Method for 2009, 2019, and 2025
  • JAPAN
    • TABLE 19: Japanese Market for Cystic Fibrosis: Annual Sales Estimates and Projections in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 20: Cystic Fibrosis Market in Japan: Historic Sales Analysis in US$ Million by Treatment Method for the Period 2009-2017
    • TABLE 21: Japanese Cystic Fibrosis Market Share Analysis by Treatment Method: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 22: Chinese Cystic Fibrosis Market Growth Prospects in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 23: Cystic Fibrosis Historic Market Analysis in China in US$ Million by Treatment Method: 2009-2017
    • TABLE 24: Chinese Cystic Fibrosis Market by Treatment Method: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Cystic Fibrosis Market: Competitor Market Share Scenario (in %) for 2020 & 2025
    • Market Analytics
    • TABLE 25: European Cystic Fibrosis Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 26: Cystic Fibrosis Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 27: European Cystic Fibrosis Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 28: European Cystic Fibrosis Market Estimates and Forecasts in US$ Million by Treatment Method: 2018-2025
    • TABLE 29: Cystic Fibrosis Market in Europe in US$ Million by Treatment Method: A Historic Review for the Period 2009-2017
    • TABLE 30: European Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 31: Cystic Fibrosis Market in France by Treatment Method: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 32: French Cystic Fibrosis Historic Market Scenario in US$ Million by Treatment Method: 2009-2017
    • TABLE 33: French Cystic Fibrosis Market Share Analysis by Treatment Method: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 34: Cystic Fibrosis Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 35: German Cystic Fibrosis Historic Market Analysis in US$ Million by Treatment Method: 2009-2017
    • TABLE 36: German Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 37: Italian Cystic Fibrosis Market Growth Prospects in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 38: Cystic Fibrosis Historic Market Analysis in Italy in US$ Million by Treatment Method: 2009-2017
    • TABLE 39: Italian Cystic Fibrosis Market by Treatment Method: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 40: United Kingdom Market for Cystic Fibrosis: Annual Sales Estimates and Projections in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 41: Cystic Fibrosis Market in the United Kingdom: Historic Sales Analysis in US$ Million by Treatment Method for the Period 2009-2017
    • TABLE 42: United Kingdom Cystic Fibrosis Market Share Analysis by Treatment Method: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 43: Spanish Cystic Fibrosis Market Estimates and Forecasts in US$ Million by Treatment Method: 2018 to 2025
    • TABLE 44: Spanish Cystic Fibrosis Historic Market Review by Treatment Method in US$ Million: 2009-2017
    • TABLE 45: Cystic Fibrosis Market in Spain: Percentage Share Breakdown of Sales by Treatment Method for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 46: Russian Cystic Fibrosis Market Estimates and Projections in US$ Million by Treatment Method: 2018 to 2025
    • TABLE 47: Cystic Fibrosis Market in Russia by Treatment Method: A Historic Review in US$ Million for 2009-2017
    • TABLE 48: Russian Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Cystic Fibrosis Market Estimates and Forecasts in US$ Million by Treatment Method: 2018-2025
    • TABLE 50: Cystic Fibrosis Market in Rest of Europe in US$ Million by Treatment Method: A Historic Review for the Period 2009-2017
    • TABLE 51: Rest of Europe Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 52: Asia-Pacific Cystic Fibrosis Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 53: Cystic Fibrosis Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 54: Asia-Pacific Cystic Fibrosis Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 55: Cystic Fibrosis Market in Asia-Pacific by Treatment Method: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 56: Asia-Pacific Cystic Fibrosis Historic Market Scenario in US$ Million by Treatment Method: 2009-2017
    • TABLE 57: Asia-Pacific Cystic Fibrosis Market Share Analysis by Treatment Method: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 58: Cystic Fibrosis Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 59: Australian Cystic Fibrosis Historic Market Analysis in US$ Million by Treatment Method: 2009-2017
    • TABLE 60: Australian Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 61: Indian Cystic Fibrosis Market Estimates and Forecasts in US$ Million by Treatment Method: 2018 to 2025
    • TABLE 62: Indian Cystic Fibrosis Historic Market Review by Treatment Method in US$ Million: 2009-2017
    • TABLE 63: Cystic Fibrosis Market in India: Percentage Share Breakdown of Sales by Treatment Method for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 64: Cystic Fibrosis Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 65: South Korean Cystic Fibrosis Historic Market Analysis in US$ Million by Treatment Method: 2009-2017
    • TABLE 66: Cystic Fibrosis Market Share Distribution in South Korea by Treatment Method: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 67: Rest of Asia-Pacific Market for Cystic Fibrosis: Annual Sales Estimates and Projections in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 68: Cystic Fibrosis Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Treatment Method for the Period 2009-2017
    • TABLE 69: Rest of Asia-Pacific Cystic Fibrosis Market Share Analysis by Treatment Method: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 70: Latin American Cystic Fibrosis Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 71: Cystic Fibrosis Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 72: Latin American Cystic Fibrosis Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 73: Latin American Cystic Fibrosis Market Growth Prospects in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 74: Cystic Fibrosis Historic Market Analysis in Latin America in US$ Million by Treatment Method: 2009-2017
    • TABLE 75: Latin American Cystic Fibrosis Market by Treatment Method: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 76: Argentinean Cystic Fibrosis Market Estimates and Forecasts in US$ Million by Treatment Method: 2018-2025
    • TABLE 77: Cystic Fibrosis Market in Argentina in US$ Million by Treatment Method: A Historic Review for the Period 2009-2017
    • TABLE 78: Argentinean Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 79: Cystic Fibrosis Market in Brazil by Treatment Method: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 80: Brazilian Cystic Fibrosis Historic Market Scenario in US$ Million by Treatment Method: 2009-2017
    • TABLE 81: Brazilian Cystic Fibrosis Market Share Analysis by Treatment Method: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 82: Cystic Fibrosis Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 83: Mexican Cystic Fibrosis Historic Market Analysis in US$ Million by Treatment Method: 2009-2017
    • TABLE 84: Mexican Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 85: Rest of Latin America Cystic Fibrosis Market Estimates and Projections in US$ Million by Treatment Method: 2018 to 2025
    • TABLE 86: Cystic Fibrosis Market in Rest of Latin America by Treatment Method: A Historic Review in US$ Million for 2009-2017
    • TABLE 87: Rest of Latin America Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 88: The Middle East Cystic Fibrosis Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 89: Cystic Fibrosis Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 90: The Middle East Cystic Fibrosis Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 91: The Middle East Cystic Fibrosis Market Estimates and Forecasts in US$ Million by Treatment Method: 2018 to 2025
    • TABLE 92: The Middle East Cystic Fibrosis Historic Market by Treatment Method in US$ Million: 2009-2017
    • TABLE 93: Cystic Fibrosis Market in the Middle East: Percentage Share Breakdown of Sales by Treatment Method for 2009, 2019, and 2025
  • IRAN
    • TABLE 94: Iranian Market for Cystic Fibrosis: Annual Sales Estimates and Projections in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 95: Cystic Fibrosis Market in Iran: Historic Sales Analysis in US$ Million by Treatment Method for the Period 2009-2017
    • TABLE 96: Iranian Cystic Fibrosis Market Share Analysis by Treatment Method: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 97: Israeli Cystic Fibrosis Market Estimates and Forecasts in US$ Million by Treatment Method: 2018-2025
    • TABLE 98: Cystic Fibrosis Market in Israel in US$ Million by Treatment Method: A Historic Review for the Period 2009-2017
    • TABLE 99: Israeli Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 100: Saudi Arabian Cystic Fibrosis Market Growth Prospects in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 101: Cystic Fibrosis Historic Market Analysis in Saudi Arabia in US$ Million by Treatment Method: 2009-2017
    • TABLE 102: Saudi Arabian Cystic Fibrosis Market by Treatment Method: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 103: Cystic Fibrosis Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 104: United Arab Emirates Cystic Fibrosis Historic Market Analysis in US$ Million by Treatment Method: 2009-2017
    • TABLE 105: Cystic Fibrosis Market Share Distribution in United Arab Emirates by Treatment Method: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 106: Cystic Fibrosis Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Treatment Method for the Period 2018-2025
    • TABLE 107: Rest of Middle East Cystic Fibrosis Historic Market Analysis in US$ Million by Treatment Method: 2009-2017
    • TABLE 108: Rest of Middle East Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 109: African Cystic Fibrosis Market Estimates and Projections in US$ Million by Treatment Method: 2018 to 2025
    • TABLE 110: Cystic Fibrosis Market in Africa by Treatment Method: A Historic Review in US$ Million for 2009-2017
    • TABLE 111: African Cystic Fibrosis Market Share Breakdown by Treatment Method: 2009 VS 2019 VS 2025

IV. COMPETITION

  • Total Companies Profiled: 56
  • CYSTIC FIBROSIS MCP-6233
  • CONTENTS